Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT06327672Recruiting

INOCA Spanish National Registry

Role: collaborator

NCT04463706Completed

COVID19 Severity Prediction and Health Services Research Evaluation

Role: collaborator

NCT06108271Not ApplicableUnknown

Innovative Endotracheal Tube Design Reduces Postoperative Laryngeal Injury

Role: lead

NCT06031766Unknown

Comparison of CIPA With the GLIM Criteria and Prevalence of Sarcopenia in Inpatients

Role: lead

NCT04501926Unknown

Genomics and Metagenomics of Asthma Severity

Role: collaborator

NCT02721706Not ApplicableCompleted

Cost-effectiveness Study of the New Nutrition Screening Tool CIPA at Hospital Admission

Role: lead

NCT02352220Unknown

Determinants of Onset and Progression of COPD in Young Adults

Role: collaborator

NCT01299922Phase 3Withdrawn

Clinical Trial Treatment in Lupus Nephritis

Role: collaborator

NCT01217151Not ApplicableCompleted

Perioperative Hemodynamic Optimization Using the NICOM Device

Role: collaborator

NCT01574547Completed

Risk Factors of Cat Scratch Colon Developing.

Role: lead

All 10 trials loaded